rs2228046

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002184.4(IL6ST):​c.1361T>C​(p.Ile454Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0158 in 1,612,922 control chromosomes in the GnomAD database, including 3,480 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.085 ( 1852 hom., cov: 32)
Exomes 𝑓: 0.0086 ( 1628 hom. )

Consequence

IL6ST
NM_002184.4 missense

Scores

1
7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.33

Publications

19 publications found
Variant links:
Genes affected
IL6ST (HGNC:6021): (interleukin 6 cytokine family signal transducer) The protein encoded by this gene is a signal transducer shared by many cytokines, including interleukin 6 (IL6), ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), and oncostatin M (OSM). This protein functions as a part of the cytokine receptor complex. The activation of this protein is dependent upon the binding of cytokines to their receptors. vIL6, a protein related to IL6 and encoded by the Kaposi sarcoma-associated herpesvirus, can bypass the interleukin 6 receptor (IL6R) and directly activate this protein. Knockout studies in mice suggest that this gene plays a critical role in regulating myocyte apoptosis. Alternatively spliced transcript variants have been described. A related pseudogene has been identified on chromosome 17. [provided by RefSeq, May 2014]
IL6ST Gene-Disease associations (from GenCC):
  • hyper-IgE recurrent infection syndrome 4A, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hyper-IgE recurrent infection syndrome 4, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004338354).
BP6
Variant 5-55954899-A-G is Benign according to our data. Variant chr5-55954899-A-G is described in ClinVar as Benign. ClinVar VariationId is 1170115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL6STNM_002184.4 linkc.1361T>C p.Ile454Thr missense_variant Exon 11 of 17 ENST00000381298.7 NP_002175.2 P40189-1Q17RA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL6STENST00000381298.7 linkc.1361T>C p.Ile454Thr missense_variant Exon 11 of 17 1 NM_002184.4 ENSP00000370698.2 P40189-1

Frequencies

GnomAD3 genomes
AF:
0.0846
AC:
12874
AN:
152142
Hom.:
1846
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0342
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.0645
GnomAD2 exomes
AF:
0.0214
AC:
5373
AN:
251074
AF XY:
0.0153
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.0131
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000590
Gnomad OTH exome
AF:
0.0123
GnomAD4 exome
AF:
0.00860
AC:
12560
AN:
1460662
Hom.:
1628
Cov.:
29
AF XY:
0.00735
AC XY:
5342
AN XY:
726722
show subpopulations
African (AFR)
AF:
0.300
AC:
10003
AN:
33388
American (AMR)
AF:
0.0151
AC:
676
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.000766
AC:
66
AN:
86166
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.0139
AC:
80
AN:
5764
European-Non Finnish (NFE)
AF:
0.000445
AC:
494
AN:
1111080
Other (OTH)
AF:
0.0205
AC:
1239
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
446
892
1338
1784
2230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0848
AC:
12919
AN:
152260
Hom.:
1852
Cov.:
32
AF XY:
0.0821
AC XY:
6115
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.294
AC:
12195
AN:
41494
American (AMR)
AF:
0.0341
AC:
522
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000926
AC:
63
AN:
68030
Other (OTH)
AF:
0.0639
AC:
135
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
464
927
1391
1854
2318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0170
Hom.:
620
Bravo
AF:
0.0964
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.282
AC:
1244
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.0265
AC:
3215
Asia WGS
AF:
0.0160
AC:
57
AN:
3476
EpiCase
AF:
0.00120
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

IL6ST-related disorder Benign:1
Dec 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.58
D;D;D
Eigen
Benign
-0.020
Eigen_PC
Benign
0.018
FATHMM_MKL
Benign
0.62
D
LIST_S2
Uncertain
0.89
.;D;.
MetaRNN
Benign
0.0043
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
M;M;M
PhyloP100
6.3
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-2.9
D;D;.
REVEL
Benign
0.15
Sift
Uncertain
0.0040
D;D;.
Sift4G
Uncertain
0.0060
D;D;D
Polyphen
0.31
B;B;B
Vest4
0.53
MPC
0.40
ClinPred
0.046
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.42
gMVP
0.81
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228046; hg19: chr5-55250727; COSMIC: COSV61140364; API